Bill
Bill > SB1551
OK SB1551
OK SB1551Pharmaceutical advertising; prohibiting direct-to-consumer advertising; providing administrative penalties. Effective date.
summary
Introduced
02/02/2026
02/02/2026
In Committee
02/03/2026
02/03/2026
Crossed Over
Passed
Dead
Introduced Session
2026 Regular Session
Bill Summary
An Act relating to pharmaceutical advertising; defining term; prohibiting direct-to-consumer pharmaceutical advertising; providing for administrative penalties; authorizing promulgation of rules; providing for codification; and providing an effective date.
AI Summary
This bill prohibits direct-to-consumer pharmaceutical advertising, which is defined as any promotional communication, including through television, radio, print, digital platforms, and social media, that markets prescription drugs directly to consumers within the state of Oklahoma. The State Board of Pharmacy is authorized to impose administrative penalties of up to $10,000 per day for each violation of this prohibition or any rules adopted to implement it, with each day a violation continues counting as a separate offense. The bill also allows the Board to create necessary rules and will take effect on November 1, 2026.
Committee Categories
Business and Industry
Sponsors (1)
Last Action
Second Reading referred to Business and Insurance (on 02/03/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | http://www.oklegislature.gov/BillInfo.aspx?Bill=sb1551&Session=2600 |
| Fiscal Note/Analysis - Senate: Introduced | https://www.oklegislature.gov/cf_pdf/2025-26%20SUPPORT%20DOCUMENTS/BILLSUM/Senate/SB1551%20INT%20BILLSUM.PDF |
| BillText | https://www.oklegislature.gov/cf_pdf/2025-26%20INT/SB/SB1551%20INT.PDF |
Loading...